NIH-funded research R15 grant

How prolactin from fat cells affects breast cancer progression

Official title: Role of prolactin in adipocyte-breast cancer cell crosstalk

Funded at University of Toledo · NIH-10358133 · Data updated 2026-11-12

This study is looking at how a hormone called prolactin, made by fat cells, might help breast cancer grow and spread, with the hope of finding new ways to predict and treat the disease for patients.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Toledo
NIH-funded
Lab location1 site (Toledo, United States)
Project startSeptember 1, 2022
Project endAugust 31, 2025
Funding year2022
Award (this year)$451,500
NIH project number1R15CA267923-01
Project IDNIH-10358133 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with breast cancer, particularly those with concerns about metastasis.

Less likely to help

Patients with non-breast cancer conditions or those without any breast cancer diagnosis may not benefit from this research.

What this research studies

This research investigates the role of prolactin, a hormone secreted by fat cells, in the development and spread of breast cancer. It aims to understand how prolactin activates a specific protein, PAK1, which may influence the behavior of breast cancer cells. By studying the interactions between adipocytes (fat cells) and breast cancer cells, the research seeks to identify new diagnostic tools that could predict the metastatic potential of breast cancer. Patients may benefit from insights that could lead to improved treatment strategies based on these mechanisms.

Why it matters

Potential benefit: If successful, this research could lead to new diagnostic tools for assessing breast cancer aggressiveness and potential treatment options.

How similar studies have gone: While the specific approach of linking prolactin and PAK1 in breast cancer is novel, similar studies have shown promise in understanding hormone interactions in cancer progression.

Where this research is happening

  • University of Toledo
    Toledo, United States
    Active

Researchers

  • Principal investigator: Diakonova, Maria — University of Toledo
  • Study coordinator: Diakonova, Maria

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.